Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
180 participants
OBSERVATIONAL
1993-04-30
1999-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medication Adherence Enhancement in Heart Transplant Recipients
NCT00843960
Anticoagulation Adherence Measurement Strategies
NCT07129395
Novel Approaches for Quantitative Assessment of Adherence
NCT04535934
Evaluating ActionADE on Adverse Drug Event Due to Non-Adherence
NCT04574648
Federal Study of Adherence to Medications in the Elderly (FAME)
NCT00393419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Statistical analysis of monitor records and new patient outcome data continues
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Renal transplant recipient
Recipients of successful renal transplant
observation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Discharged from hospital with functioning graft,not on dialysis
* Prescribed azathioprine
Exclusion Criteria
* Non English speaking
* Previous or concurrent organ transplant other than kidney
* Taking liquid form of azathioprine
* Followed outside of the United states
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thomas E. Nivens, MD
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas E Nevins, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int. 2001 Oct;60(4):1565-70. doi: 10.1046/j.1523-1755.2001.00961.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH - DK13083
Identifier Type: -
Identifier Source: secondary_id
9109M04306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.